CancerChoices reviews and synthesizes the evidence behind complementary therapies including repurposed drugs. Given the significant interest in our review of Mebendazole and Fenbendazole, and our accompanying article on repurposed drugs, we’ve partnered with Mark Taylor of Patient Led Oncology to provide a deeper analysis of Fenbendazole.